Views & Analysis Cost concerns with the new NHS pricing scheme A new pricing scheme, which took effect this month, has raised the cap on NHS spending on branded drugs slightly.
Partner Content Partner Content SMi’s Drug Discovery Chemistry announces key industry speake... SMi’s Drug Discovery Chemistry brochure available
Partner Content Partner Content 3rd Microbiome Movement - Drug Development Europe New Speakers: Microbiome Drug Development Europe Summit
Events Partner Content 3rd Microbiome Movement - Drug Development Europe Recent breakthroughs in DNA sequencing, metagenomic analysis and computational techniques have given scientists new insight into the structure and function of the human microbiota, an interconnecte
Partner Content Partner Content Regulatory Issues for PF Syringes & Injectable Drug Devi... Pre-Filled Syringes & Injectable Drug Devices Europe
Partner Content Partner Content Preliminary Attendee List Released for Orphan Drugs & Rare D... Attendees Released for Orphan Drugs & Rare Diseases
News Repligen builds in cell therapy with $1.5bn BioLife takeover Repligen has reached a deal to buy cell therapy specialist BioLife Solutions for $1.5bn, tapping into a market growing at breakneck speed.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
